Gronghui APP was informed that according to the latest equity disclosure information of the Stock Exchange, on June 21, 2022, East Rui Pharmaceutical (02348.HK) was increased by non-executive director Liang Kangmin to hold 64000 shares at an average price of HK $1.2538 per share, involving a capital of about HK $80200.

After the increase, Liang Kangmin's latest number of shares is 105524000 shares, with a shareholding ratio of 7.04 per cent.